Vanguard Group
LTRN icon

Vanguard Group’s Lantern Pharma LTRN Stock Holding History

Vanguard Group’s Portfolio LTRN Stock Details LTRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$1.16M Hold
384,041
– – ﹤0.01% 3736
2025
Q3 		$1.67M Buy
384,041
+20,321
+6% +$84.8K ﹤0.01% 3632
2025
Q2 		$1.15M Hold
363,720
– – ﹤0.01% 3704
2025
Q1 		$1.29M Hold
363,720
– – ﹤0.01% 3632
2024
Q4 		$1.16M Hold
363,720
– – ﹤0.01% 3714
2024
Q3 		$1.33M Hold
363,720
– – ﹤0.01% 3684
2024
Q2 		$1.7M Hold
363,720
– – ﹤0.01% 3610
2024
Q1 		$3.2M Sell
363,720
-1,614
-0.4% -$8.62K ﹤0.01% 3446
2023
Q4 		$1.56M Sell
365,334
-2,120
-0.6% -$7.48K ﹤0.01% 3686
2023
Q3 		$1.25M Hold
367,454
– – ﹤0.01% 3752
2023
Q2 		$2.07M Hold
367,454
– – ﹤0.01% 3640
2023
Q1 		$1.77M Hold
367,454
– – ﹤0.01% 3720
2022
Q4 		$2.22M Buy
367,454
+135
+0% +$676 ﹤0.01% 3624
2022
Q3 		$1.76M Hold
367,319
– – ﹤0.01% 3795
2022
Q2 		$2.1M Hold
367,319
– – ﹤0.01% 3786
2022
Q1 		$2.63M Sell
367,319
-1,385
-0.4% -$9.25K ﹤0.01% 3847
2021
Q4 		$2.94M Buy
368,704
+97,884
+36% +$894K ﹤0.01% 3878
2021
Q3 		$3.03M Buy
270,820
+1,391
+0.5% +$18K ﹤0.01% 3910
2021
Q2 		$3.93M Buy
269,429
+10,282
+4% +$159K ﹤0.01% 3713
2021
Q1 		$4.7M Buy
+259,147
New +$4.54M ﹤0.01% 3563

Other funds holding LTRN

BCM
BIOS Capital Management Fort Worth, Texas $52.9M AUM 30.51% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VC
Voss Capital Houston, Texas $1.88B AUM 1.03% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
NA
NewEdge Advisors New Orleans, Louisiana $27.7B AUM 22.98% 1-Year Est. Return
WIM
Westside Investment Management Santa Monica, California $761M AUM 39.85% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Vanguard Group's LTRN Position: Q4 2025 in Review

Vanguard Group held its Lantern Pharma (LTRN) position steady in Q4 2025 at 384,041 shares worth $1.16M. The position accounts for ﹤0.01% of the portfolio, ranked #3736.

Vanguard Group first reported a position in LTRN in Q1 2021 and has held it in 20 quarters since. The position peaked at $4.7M in Q1 2021. 33 funds tracked by Wall St. Rank hold LTRN as of Q4 2025.

  • Vanguard Group held 384,041 shares of Lantern Pharma worth $1.16M as of Q4 2025.
  • Vanguard Group left its Lantern Pharma share count unchanged in Q4 2025.
  • Lantern Pharma made up ﹤0.01% of Vanguard Group's portfolio in Q4 2025, its #3736 holding.
  • Vanguard Group first reported a position in Lantern Pharma in Q1 2021 and has held it in 20 quarters since.
  • Vanguard Group's Lantern Pharma position peaked at $4.7M in Q1 2021.
  • 33 funds tracked by Wall St. Rank held Lantern Pharma as of Q4 2025.

Based on Vanguard Group's 13F filing for Q4 2025, filed 29 Jan 2026.